Common drug may stop pancreatitis after bile duct procedure
NCT ID NCT06860984
First seen Nov 18, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tests whether the drug duloxetine can prevent pancreatitis, a painful complication that sometimes happens after a procedure called ERCP (used to diagnose and treat bile duct problems). The trial will enroll 44 adults with biliary disease who are scheduled for ERCP. Half will receive duloxetine before the procedure, and researchers will check if fewer of them develop pancreatitis compared to those who do not receive the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tanta Unuversity
RECRUITINGTanta, 31527, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.